Skip to main content
Top
Published in: BMC Pediatrics 1/2022

Open Access 01-12-2022 | Heart Surgery | Research

Impact of tight glycemic control and hypoglycemia after pediatric cardiac surgery on neurodevelopmental outcomes at three years of age: Findings from a randomized clinical trial

Authors: Anjali Sadhwani, Lisa A. Asaro, Caren S. Goldberg, Janice Ware, Jennifer Butcher, Michael Gaies, Cynthia Smith, Jamin L. Alexander, David Wypij, Michael S. D. Agus

Published in: BMC Pediatrics | Issue 1/2022

Login to get access

Abstract

Background

Studies examining the impact of randomization As per standard instruction, city is required for affiliations; however, this information is missing in affiliation 6. Please check if the provided city is correct and amend if necessary. to tight glycemic control (TGC) and resultant hypoglycemia on later neurodevelopmental outcomes have produced mixed results. Our study examined this association in children undergoing cardiac surgery.

Methods

Participants who were enrolled in the Safe Pediatric Euglycemia after Cardiac Surgery (SPECS) trial returned for neurodevelopmental (ND) follow-up between 30 to 42.5 months of age. ND outcomes were assessed using the Bayley Scales of Infant and Toddler Development, Third Edition. ND scores were compared between the TGC and standard care treatment groups and between patients with moderate to severe and no to mild hypoglycemia. As a secondary analysis, to increase sample size and power, we combined the three-year-old assessments with previously collected assessments done at < 30 months of age to further examine differences between groups longitudinally.

Results

Among the 269 participants who completed neurodevelopmental evaluation (in-person testing or questionnaires) at three years of age (follow-up rate, 31%), there were no statistically significant differences in ND outcomes according to treatment group or hypoglycemia status. In the combined analysis of all evaluations (from 9 to 42.5 months of age), we found no treatment group differences. However, in these longitudinal analyses, children who experienced moderate to severe hypoglycemia had lower scores on the Bayley-III cognitive and motor domains compared to children with no to mild hypoglycemia.

Conclusions

For infants undergoing cardiac surgery, there was no impact of tight glycemic control on neurodevelopmental outcomes. Moderate to severe hypoglycemia was associated with worse ND outcomes in longitudinal analyses.

Trial registration

ClinicalTrials.gov NCT00443599. Registered: November 2016.
Literature
1.
go back to reference Zhao Y, Wu Y, Xiang B. Tight glycemic control in critically ill pediatric patients: a meta-analysis and systematic review of randomized controlled trials. Pediatr Res. 2018;84(1):22–7.CrossRefPubMed Zhao Y, Wu Y, Xiang B. Tight glycemic control in critically ill pediatric patients: a meta-analysis and systematic review of randomized controlled trials. Pediatr Res. 2018;84(1):22–7.CrossRefPubMed
2.
go back to reference Yamada T, Shojima N, Hara K, Noma H, Yamauchi T, Kadowaki T. Glycemic control, mortality, secondary infection, and hypoglycemia in critically ill pediatric patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med. 2017;43(9):1427–9.CrossRefPubMed Yamada T, Shojima N, Hara K, Noma H, Yamauchi T, Kadowaki T. Glycemic control, mortality, secondary infection, and hypoglycemia in critically ill pediatric patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med. 2017;43(9):1427–9.CrossRefPubMed
3.
go back to reference Faustino EVS, Hirshberg EL, Asaro LA, Biagas KV, Pinto N, Srinivasan V, et al. Short-term adverse outcomes associated with hypoglycemia in critically ill children. Crit Care Med. 2019;47(5):706–14.CrossRefPubMed Faustino EVS, Hirshberg EL, Asaro LA, Biagas KV, Pinto N, Srinivasan V, et al. Short-term adverse outcomes associated with hypoglycemia in critically ill children. Crit Care Med. 2019;47(5):706–14.CrossRefPubMed
4.
go back to reference Chen L, Li T, Fang F, Zhang Y, Faramand A. Tight glycemic control in critically ill pediatric patients: a systematic review and meta-analysis. Crit Care. 2018;22(1):57.CrossRefPubMedPubMedCentral Chen L, Li T, Fang F, Zhang Y, Faramand A. Tight glycemic control in critically ill pediatric patients: a systematic review and meta-analysis. Crit Care. 2018;22(1):57.CrossRefPubMedPubMedCentral
6.
go back to reference Biagas KV, Hinton VJ, Hasbani NR, Luckett PM, Wypij D, Nadkarni VM, Agus MSD. HALF-PINT trial study investigators; PALISI Network. Long-term neurobehavioral and quality of life outcomes of critically Ill children after glycemic control. J Pediatr. 2020;218(57):63-e5. Biagas KV, Hinton VJ, Hasbani NR, Luckett PM, Wypij D, Nadkarni VM, Agus MSD. HALF-PINT trial study investigators; PALISI Network. Long-term neurobehavioral and quality of life outcomes of critically Ill children after glycemic control. J Pediatr. 2020;218(57):63-e5.
7.
go back to reference Mesotten D, Gielen M, Sterken C, Claessens K, Hermans G, Vlasselaers D, et al. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA. 2012;308(16):1641–50.CrossRefPubMed Mesotten D, Gielen M, Sterken C, Claessens K, Hermans G, Vlasselaers D, et al. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA. 2012;308(16):1641–50.CrossRefPubMed
8.
go back to reference Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373(9663):547–56.CrossRefPubMed Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373(9663):547–56.CrossRefPubMed
9.
go back to reference Sadhwani A, Asaro LA, Goldberg C, Ware J, Butcher J, Gaies M, et al. Impact of tight glycemic control on neurodevelopmental outcomes at 1 year of age for children with congenital heart disease: a randomized controlled trial. J Pediatr. 2016;174:193-8.e2.CrossRefPubMedPubMedCentral Sadhwani A, Asaro LA, Goldberg C, Ware J, Butcher J, Gaies M, et al. Impact of tight glycemic control on neurodevelopmental outcomes at 1 year of age for children with congenital heart disease: a randomized controlled trial. J Pediatr. 2016;174:193-8.e2.CrossRefPubMedPubMedCentral
10.
go back to reference Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012;367(13):1208–19.CrossRefPubMedPubMedCentral Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012;367(13):1208–19.CrossRefPubMedPubMedCentral
11.
go back to reference Gaies MG, Langer M, Alexander J, Steil GM, Ware J, Wypij D, et al. Design and rationale of safe pediatric euglycemia after cardiac surgery: a randomized controlled trial of tight glycemic control after pediatric cardiac surgery. Pediatr Crit Care Med. 2013;14(2):148–56.CrossRefPubMedPubMedCentral Gaies MG, Langer M, Alexander J, Steil GM, Ware J, Wypij D, et al. Design and rationale of safe pediatric euglycemia after cardiac surgery: a randomized controlled trial of tight glycemic control after pediatric cardiac surgery. Pediatr Crit Care Med. 2013;14(2):148–56.CrossRefPubMedPubMedCentral
12.
go back to reference Agus MS, Asaro LA, Steil GM, Alexander JL, Silverman M, Wypij D, et al. Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trial. Circulation. 2014;129(22):2297–304.CrossRefPubMedPubMedCentral Agus MS, Asaro LA, Steil GM, Alexander JL, Silverman M, Wypij D, et al. Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trial. Circulation. 2014;129(22):2297–304.CrossRefPubMedPubMedCentral
13.
go back to reference Bayley N. Bayley Scales of infant and toddler development. 3rd ed. San Antonio, TX: Pearson education; 2006. Bayley N. Bayley Scales of infant and toddler development. 3rd ed. San Antonio, TX: Pearson education; 2006.
14.
go back to reference Harrison PL, Oakland T, Angeles CA. Adaptive behavior assessment system. 2nd ed. San Antonio, TX, Pearson education; 2003. Harrison PL, Oakland T, Angeles CA. Adaptive behavior assessment system. 2nd ed. San Antonio, TX, Pearson education; 2003.
15.
go back to reference Reynolds CR, Kamphaus RW. Behavior assessment system for children. 2nd ed. Circle Pines, MN: Am Guid Serv; 2004. Reynolds CR, Kamphaus RW. Behavior assessment system for children. 2nd ed. Circle Pines, MN: Am Guid Serv; 2004.
16.
go back to reference Squires J, Bricker D. Ages and stages questionnaires. A parent completed child-monitoring system. 3rd ed. Baltimore: Paul Brookes publishing; 2009. Squires J, Bricker D. Ages and stages questionnaires. A parent completed child-monitoring system. 3rd ed. Baltimore: Paul Brookes publishing; 2009.
17.
go back to reference Gaynor JW, Wernovsky G, Jarvik GP, Bernbaum J, Gerdes M, Zackai E, et al. Patient characteristics are important determinants of neurodevelopmental outcome at one year of age after neonatal and infant cardiac surgery. J Thorac Cardiovasc Surg. 2007;133(5):1344–53 53 e1 3.CrossRefPubMedPubMedCentral Gaynor JW, Wernovsky G, Jarvik GP, Bernbaum J, Gerdes M, Zackai E, et al. Patient characteristics are important determinants of neurodevelopmental outcome at one year of age after neonatal and infant cardiac surgery. J Thorac Cardiovasc Surg. 2007;133(5):1344–53 53 e1 3.CrossRefPubMedPubMedCentral
18.
go back to reference Zeltser I, Jarvik GP, Bernbaum J, Wernovsky G, Nord AS, Gerdes M, et al. Genetic factors are important determinants of neurodevelopmental outcome after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2008;135(1):91–7.CrossRefPubMed Zeltser I, Jarvik GP, Bernbaum J, Wernovsky G, Nord AS, Gerdes M, et al. Genetic factors are important determinants of neurodevelopmental outcome after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2008;135(1):91–7.CrossRefPubMed
19.
go back to reference Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002;123(1):110–8.CrossRefPubMed Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002;123(1):110–8.CrossRefPubMed
20.
go back to reference Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatr. 2008;122(1):65–74.CrossRef Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatr. 2008;122(1):65–74.CrossRef
21.
go back to reference McKinlay CJD, Alsweiler JM, Anstice NS, Burakevych N, Chakraborty A, Chase JG, et al. Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years. JAMA Pediatr. 2017;171(10):972–83.CrossRefPubMedPubMedCentral McKinlay CJD, Alsweiler JM, Anstice NS, Burakevych N, Chakraborty A, Chase JG, et al. Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years. JAMA Pediatr. 2017;171(10):972–83.CrossRefPubMedPubMedCentral
22.
go back to reference Kaiser JR, Bai S, Gibson N, Holland G, Lin TM, Swearingen CJ, et al. Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study. JAMA Pediatr. 2015;169(10):913–21.CrossRefPubMed Kaiser JR, Bai S, Gibson N, Holland G, Lin TM, Swearingen CJ, et al. Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study. JAMA Pediatr. 2015;169(10):913–21.CrossRefPubMed
23.
go back to reference Shah R, Harding J, Brown J, McKinlay C. Neonatal glycaemia and neurodevelopmental outcomes: a systematic review and meta-analysis. Neonatology. 2019;115(2):116–26.CrossRefPubMed Shah R, Harding J, Brown J, McKinlay C. Neonatal glycaemia and neurodevelopmental outcomes: a systematic review and meta-analysis. Neonatology. 2019;115(2):116–26.CrossRefPubMed
24.
go back to reference McGrath E, Wypij D, Rappaport LA, Newburger JW, Bellinger DC. Prediction of IQ and achievement at age 8 years from neurodevelopmental status at age 1 year in children with D-transposition of the great arteries. Pediatr. 2004;114(5):e572–6.CrossRef McGrath E, Wypij D, Rappaport LA, Newburger JW, Bellinger DC. Prediction of IQ and achievement at age 8 years from neurodevelopmental status at age 1 year in children with D-transposition of the great arteries. Pediatr. 2004;114(5):e572–6.CrossRef
Metadata
Title
Impact of tight glycemic control and hypoglycemia after pediatric cardiac surgery on neurodevelopmental outcomes at three years of age: Findings from a randomized clinical trial
Authors
Anjali Sadhwani
Lisa A. Asaro
Caren S. Goldberg
Janice Ware
Jennifer Butcher
Michael Gaies
Cynthia Smith
Jamin L. Alexander
David Wypij
Michael S. D. Agus
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2022
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-022-03556-z

Other articles of this Issue 1/2022

BMC Pediatrics 1/2022 Go to the issue